{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:05:20Z","timestamp":1792652720542,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s11010-005-6604-1","type":"journal-article","created":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T09:40:25Z","timestamp":1115113225000},"page":"29-34","source":"Crossref","is-referenced-by-count":117,"title":["Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria"],"prefix":"10.1007","volume":"272","author":[{"given":"Harry G.","family":"Preuss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Echard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Enig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","volume-title":"OTA-H-629","author":"U.S. Congress","year":"1995","unstructured":"U.S. Congress, Office of Technology Assessment: Impacts of antibiotic resistant bacteria, OTA-H-629. U.S. Government Printing Office, Washington DC; 1995"},{"issue":"Suppl 1","key":"CR2","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1093\/clinids\/24.Supplement_1.S74","volume":"24","author":"GA Ayliffe","year":"1997","unstructured":"Ayliffe GA: The progressive intercontinental spreads of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 24(Suppl 1): S74\u2013S79, 1997","journal-title":"Clin Infect Dis"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/srin.2002.34692","volume":"17","author":"BA Cunha","year":"2002","unstructured":"Cunha BA: Strategies to control antibiotic resistance. Sem Resp Infect 17: 250\u2013258, 2002","journal-title":"Sem Resp Infect"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-124-3-199602010-00008","volume":"124","author":"MB Edmond","year":"1996","unstructured":"Edmond MB, Wenzel RP, Pasculle AW: Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control. Ann Intern Med 124: 329\u2013334, 1996","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199902183400709","volume":"340","author":"WW Waldvogel","year":"1999","unstructured":"Waldvogel WW: New resistance in Staphylococcus aureus. N Eng J Med 340: 556\u2013557, 1999","journal-title":"N Eng J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/314035","volume":"31","author":"J Burnie","year":"2000","unstructured":"Burnie J, Matthews R, Jiman-Fatami A, Gottardello P, Hodgetts S, D\u2019arcy S: Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: Evidence of resistance to vancomycin. Clin Infect Dis 31: 684\u2013689, 2000","journal-title":"Clin Infect Dis"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","volume":"40","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Hanake H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40: 135\u2013136, 1997","journal-title":"J Antimicrob Chemother"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199902183400704","volume":"340","author":"K Sieradzki","year":"1999","unstructured":"Sieradzki K, Roberts RB, Haber SW, Tomasz A: The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus infection. N Eng J Med 340: 517\u2013523, 1999","journal-title":"N Eng J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/dkf142","volume":"50","author":"O Denis","year":"2002","unstructured":"Denis O, Nonhoff C, Byl B Knoop C, Bobin-Dubreux S, Struelens MJ: Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: Microbiological and clinical features. J Antimicrob Chemother 50: 383\u2013391, 2002","journal-title":"J Antimicrob Chemother"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0924-8579(01)00464-2","volume":"18","author":"I Brook","year":"2001","unstructured":"Brook I, Elliott TB, Pryor HI, Sautter TE, Gnade BT, Thakar JH, Knudson GB. In vitro resistance of Bacillus anthracis Sterne to doxocycline, macrolides and quinolones. Intern J Antimicrob Agents 18: 559\u2013562, 2001","journal-title":"Intern J Antimicrob Agents"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1099\/0022-1317-50-8-702","volume":"50","author":"I Brook","year":"2001","unstructured":"Brook I, Elliott TB, Harding RA, Bouhaouala SS, Peacock SJ, Ledney GD, Knudson GB: Susceptibility of irradiated mice to Bacillus anthracis Sterne by the intratracheal route of infection. J Med Microbiol 50: 702\u2013711, 2001","journal-title":"J Med Microbiol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.44.6.1766-1766.2000","volume":"44","author":"CH Choe","year":"2000","unstructured":"Choe CH, Bouhaouala SS, Brook I, Elliott TB, Knudson GB: In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob Agents Chemother 44: 1766, 2000","journal-title":"Antimicrob Agents Chemother"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archinte.158.5.429","volume":"158","author":"JC Pile","year":"1998","unstructured":"Pile JC, Malone JD, Eitzen EM, Friedlander AM: Anthrax as a potential biological warfare agent. Arch Intern Med 158: 429\u2013434, 1998","journal-title":"Arch Intern Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/314007","volume":"31","author":"CR Horsburgh Jr","year":"2000","unstructured":"Horsburgh Jr CR, Felman S, Ridzon R: Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 31: 633\u2013639, 2000","journal-title":"Clin Infect Dis"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1086\/313969","volume":"31","author":"RS Remis","year":"1998","unstructured":"Remis RS, Jamieson F, Chedore P, Haddad A, Vernich L: Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987\u20131998. Clin Infect Dis 31: 427\u2013432, 1998","journal-title":"Clin Infect Dis"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1013311632207","volume":"228","author":"V Manohar","year":"2001","unstructured":"Manohar V, Ingram C, Gray J, Talpur N, Echard BW, Bagchi D, Preuss HG: Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 228: 111\u2013117, 2001","journal-title":"Mol Cell Biochem"},{"key":"CR17","first-page":"66","volume":"20","author":"V Manohar","year":"2001","unstructured":"Manohar V, Ingram C, Gray J, Talpur N, Echard BW, Preuss HG: Antibacterial effects of the edible oil of oregano against Staphlococcus aureus. J Am Coll Nutr 20: 66, 2001 (abstract)","journal-title":"J Am Coll Nutr"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0195-6701(98)90273-0","volume":"38","author":"PA Griffiths","year":"1998","unstructured":"Griffiths PA, Babb JR, Fraise AP: Mycobacterium terrae: A potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test. J Hosp Infect 38: 183\u2013192, 1998","journal-title":"J Hosp Infect"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1021\/jf00059a013","volume":"43","author":"J Kim","year":"1995","unstructured":"Kim J, Marshall MR, Wei, C-I: Antibacterial activity of some essential oil components against five foodborne pathogens. J Agric Food Chem 43: 2839\u20132845, 1995","journal-title":"J Agric Food Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/35.3.421","volume":"35","author":"CF Carson","year":"1995","unstructured":"Carson CF, Cookson BD, Farrelly HD, Riley TV: Susceptibility of methicillin resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 35: 421\u2013424, 1995","journal-title":"J Antimicrob Chemother"},{"key":"CR21","volume-title":"Beyond Antibiotics. 50 (Or So) Ways to Boost Immunity and Avoid Antibiotics","author":"MA Schmidt","year":"1994","unstructured":"Schmidt MA, Sehnert KW, Smith LH: Beyond Antibiotics. 50 (Or So) Ways to Boost Immunity and Avoid Antibiotics, North Atlantic Books, Berkeley, CA, 1994"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/j.1365-2621.1990.tb03598.x","volume":"55","author":"A Ismaiel","year":"1990","unstructured":"Ismaiel A, Pierson MD: Inhibition of growth and germination of C botulinum 33A, 40B, and 1623E by essential oil of spices. J Food Sci 55: 1676\u20131680, 1990","journal-title":"J Food Sci"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2672.1999.00669.x","volume":"86","author":"M Mansour","year":"1999","unstructured":"Mansour M, Bouttefroy AD, Linder M, Milliere JB: Inhibition of Bacillus licheniformis spore growth in milk by nisin, monolaurin and pH combinations. J Appl Microbiol 86: 311\u2013324, 1999","journal-title":"J Appl Microbiol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0168-1605(91)90140-K","volume":"13","author":"M Kivanc","year":"1991","unstructured":"Kivanc M, Akgul A, Dogan A: Inhibitory and stimulatory effects of cumin, oregano and their essential oils on growth and acid production of Lactobacillus plantarum and Leuconostoc mesenteroides. Intern J Food Microbiol 13: 81\u201386, 1991","journal-title":"Intern J Food Microbiol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1365-2672.1999.00780.x","volume":"86","author":"KA Hammer","year":"1999","unstructured":"Hammer KA, Carson CF, Riley TV: Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86: 985\u2013990, 1999","journal-title":"J Appl Microbiol"},{"key":"CR26","unstructured":"Tucker AO, Maciarello MJ: Oregano: Botany, chemistry, and cultivation. In: G. Charalambus (ed). Spices, Herbs, and Edible Fungi, Elsevier Science, St Louis, MO, 1994, pp 439\u2013456"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/jf950540t","volume":"44","author":"A Sivropoulus","year":"1996","unstructured":"Sivropoulus A, Papanikolaou E, Nikolaou C, Kokkini S, Lanaras T, Arsenakis M: Antimicrobial and cytoxic activities of origanum essential oils. J Agric Food Chem 44: 1202\u20131205, 1996","journal-title":"J Agric Food Chem"},{"key":"CR28","first-page":"185","volume":"24","author":"YM Siddiqui","year":"1996","unstructured":"Siddiqui YM, Ettayebi M, Haddad A, Al-Ahdal MN: Effect of essential oils on enveloped viruses: Antiviral activity of oregano and clove oils on Herpes simplex virus type 1 and Newcastle disease virus. Medi Sci Res 24: 185\u2013186, 1996","journal-title":"Medi Sci Res"},{"key":"CR29","first-page":"81","volume-title":"Nutrients and Foods in AI12\/3\/04","author":"MG Enig","year":"1998","unstructured":"Enig MG: Lauric oils as antimicrobial agents: Theory of effect, scientific rationale, and dietary application as adjunct nutritional support for HIV-infected individuals. In: R.R.Watson (ed). Nutrients and Foods in AI12\/3\/04 CRC Press, Boca Raton, FL, 1998, pp 81\u201397"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1753-4887.1980.tb05843.x","volume":"38","author":"JJ Kabara","year":"1980","unstructured":"Kabara JJ: Lipids as host-resistance factors of human milk. Nutr Rev 38: 65\u201373, 1980","journal-title":"Nutr Rev"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF02570908","volume":"12","author":"JJ Kabara","year":"1977","unstructured":"Kabara JJ, Vrable R: Antimicrobial lipids: Natural and synthetic acids and monoglycerides. Lipids 12: 753\u2013759, 1977","journal-title":"Lipids"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/AAC.4.5.501","volume":"4","author":"AJ Conley","year":"1973","unstructured":"Conley AJ, Kabara JJ: Antimicrobial action of esters of polyhydric alcohols. Antimicrob Agents Chemother 4: 501\u2013506, 1973","journal-title":"Antimicrob Agents Chemother"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AAC.36.3.626","volume":"36","author":"PM Schlievert","year":"1992","unstructured":"Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP: Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob Agents Chemother 36: 626\u2013631, 1992","journal-title":"Antimicrob Agents Chemother"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/jb.176.14.4204-4209.1994","volume":"176","author":"SJ Projan","year":"1994","unstructured":"Projan SJ, Brown-Skrobot S, Schlievert PM: Glycerol monolaurate inhibits the production of B-lactamase, toxic shock syndrome toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J Bacteriol 176: 4204\u20134209, 1994","journal-title":"J Bacteriol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1128\/JB.182.9.2668-2671.2000","volume":"182","author":"A Ruzin","year":"2000","unstructured":"Ruzin A, Novick RP: glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J Bacteriol 182: 2668\u20132671, 2000","journal-title":"J Bacteriol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/JB.180.1.182-185.1998","volume":"180","author":"A Ruzin","year":"1998","unstructured":"Ruzin A, Novick RP: Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis. J Bacteriol ([0-9]+): 182\u2013185, 1998","journal-title":"J Bacteriol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/AAC.42.9.2290","volume":"42","author":"G Bergsson","year":"1998","unstructured":"Bergsson G, Arnfinnsson J, Karlsson SM, Steingrimsson O, Thormar H: In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother 42: 2290\u20132294, 1998","journal-title":"Antimicrob Agents Chemother"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/AAC.31.1.27","volume":"31","author":"H Thormar","year":"1987","unstructured":"Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T: Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31: 27\u201331, 1987","journal-title":"Antimicrob Agents Chemother"},{"key":"CR39","first-page":"272","volume":"65","author":"CE Isaacs","year":"1991","unstructured":"Isaacs CE, Kashyap S, Heird WC, Thormar H: Anitiviral and antibacterial lipids in human milk and infant formula feed. Arch Dis Childhood 65: 272\u2013273, 1991","journal-title":"Arch Dis Childhood"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4615-3838-7_19","volume":"310","author":"CE Isaacs","year":"1991","unstructured":"Isaacs CE, Thormar H: The role of milk-derived antimicrobial lipids as antiviral and antibacterial agents. Adv Exper Med Biol ([0-9]+): 159\u2013165, 1991","journal-title":"Adv Exper Med Biol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/AAC.40.2.302","volume":"40","author":"BW Petschow","year":"1996","unstructured":"Petschow BW, Batema RP, Ford LL: Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 40: 302\u2013306, 1996","journal-title":"Antimicrob Agents Chemother"},{"key":"CR42","unstructured":"CDC: Helicobacter pylori and peptic ulcer disease. http:\/\/www.cdc.gov\/ulcer\/md.htm (entered May 12, 2003)"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-6604-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-005-6604-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-6604-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T05:21:48Z","timestamp":1586236908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-005-6604-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["6604"],"URL":"https:\/\/doi.org\/10.1007\/s11010-005-6604-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}